HHS Insider Trading Activity and SEC Form 4 Filings
HHS insider trading summary
No open-market insider purchases or sales of Harte Hanks Inc (HHS) have been reported on SEC Form 4 in the past 12 months.
Latest HHS insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $12 (2 @ $5.76) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $585 (100 @ $5.85) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $1K (200 @ $5.81) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $1K (200 @ $5.75) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $1K (245 @ $5.77) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $4K (627 @ $5.84) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $16K (2,853 @ $5.78) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $19K (3,306 @ $5.80) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $9K (1,594 @ $5.82) |
| Dec 5, 2024 | Bradley Louis Radoff | Director | Buy | $23K (3,997 @ $5.85) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.